CLINICAL AND VIROLOGICAL EFFECTS OF HIGH-DOSE RECOMBINANT INTERFERON-α IN DISSEMINATED AIDS-RELATED KAPOSI'S SARCOMA
- 26 November 1988
- journal article
- Published by Elsevier in The Lancet
- Vol. 332 (8622) , 1214-1217
- https://doi.org/10.1016/s0140-6736(88)90810-0
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Etoposide for epidemic Kaposi's sarcoma: A phase II studyEuropean Journal of Cancer and Clinical Oncology, 1988
- Aids-associated kaposiʼs sarcomaAIDS, 1988
- Correlation of serum HIV antigen and antibody with clinical status in HIV‐I infected patientsJournal of Medical Virology, 1987
- A simple and effective treatment for AIDS related Kaposi's sarcoma.BMJ, 1987
- Antigenemia and Antibody Titers to Core and Envelope Antigens in AIDS, AIDS-Related Complex, and Subclinical Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 1987
- Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferonAntimicrobial Agents and Chemotherapy, 1987
- Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.BMJ, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- RECOMBINANT HUMAN INTERFERON ALFA-A SUPPRESSES HTLV-III REPLICATION IN VITROThe Lancet, 1985
- Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's SarcomaNew England Journal of Medicine, 1983